Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > TSX Uplisting Expectations

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon May 31, 2022 2:22pm

126 Views

Post# 34720772

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:TSX Uplisting Expectations

Stockfshr wrote: Conformal coating questions I emailed Sernova and received no response:

I have a few questions about the worldwide exclusive conformal coating commercial licensing agreement that Sernova signed with the University of Miami.

1) Is this agreement with the university rather than the developers such as Dr. Tomei? Or are all the parties involved to varying degrees?

2) Being exclusive, does this mean that the university cannot sell the technology to another company that might compete with Sernova?

3) Is the university/Dr. Tomei still working to improve this technology? Is this for the exclusive benefit of Sernova?

4) Can the university through its Diabetes Research Institute (DRI) and BioHub become a commercial entity itself that could use the conformal technology and/or their other developing technologies to compete directly with Sernova?

Anyone on this board able to answer?

Excellent questions . Fish, Sva owns all patents and exclusivity for conformal coating worldwide period from University of Miami and from Dr Tomei.

Any further improvements to technology belong exclusively to Sva. No other entity has rights to the technology and worldwide rights .

I asked company after Doug Loe messed up his last analyst report about this .

MS

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario